Pregled bibliografske jedinice broj: 352847
The role of plasmapheresis in the treatment of amiodarone-induced thyrotoxicosis
The role of plasmapheresis in the treatment of amiodarone-induced thyrotoxicosis // Dialysis & transplantation, 36 (2007), 4; 227-229 (podatak o recenziji nije dostupan, prikaz, stručni)
CROSBI ID: 352847 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The role of plasmapheresis in the treatment of amiodarone-induced thyrotoxicosis
Autori
Korljan Babić, Betty ; Ljutić, Dragan ; Brnić, Darko ; Dodig, Josipa
Izvornik
Dialysis & transplantation (0090-2934) 36
(2007), 4;
227-229
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, prikaz, stručni
Ključne riječi
plasmapheresis; amiodaron; thyrotoxicosis; treatment
Sažetak
Thyrotoxicosis, a life-threatening condition characterized by an excess of thyroid hormones with typical clinical manifestations and high mortality, is a well-known amiodarone side effect. Amiodarone is a highly effective antiarrhythmic drug that contains 37% iodine by weight and has a structural resemblance to thyroid hormones. The average prevalence of amiodarone-induced thyrotoxicosis is about 5%. Because of long terminal half-life amiodarone-induced thyroid dysfunction is very difficult to treat by discontinuation of amiodarone and antithyroid drugs.4, 9-11 Plasmapheresis is already known as a very effective therapeutic method for patients with thyrotoxicosis.12 Here we report on a patient with thyrotoxicosis who was successfully treated with plasmapheresis.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
216-0000000-0520 - Imunološke, hematološke, reološke i druge osobitosti uremijskog sindroma (Ljutić, Dragan, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
